Axxcess Wealth Management LLC Sells 4,974 Shares of VanEck Pharmaceutical ETF (NASDAQ:PPH)

Axxcess Wealth Management LLC lowered its holdings in VanEck Pharmaceutical ETF (NASDAQ:PPH) by 51.3% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 4,713 shares of the company’s stock after selling 4,974 shares during the period. Axxcess Wealth Management LLC owned about 0.08% of VanEck Pharmaceutical ETF worth $407,000 as of its most recent SEC filing.

A number of other institutional investors have also recently bought and sold shares of the business. Bank of Montreal Can grew its position in shares of VanEck Pharmaceutical ETF by 43.6% during the 3rd quarter. Bank of Montreal Can now owns 21,640 shares of the company’s stock valued at $2,052,000 after acquiring an additional 6,570 shares during the period. FMR LLC grew its holdings in VanEck Pharmaceutical ETF by 12.5% during the third quarter. FMR LLC now owns 1,905 shares of the company’s stock valued at $181,000 after purchasing an additional 212 shares during the period. Townsquare Capital LLC increased its position in VanEck Pharmaceutical ETF by 3.8% in the third quarter. Townsquare Capital LLC now owns 3,519 shares of the company’s stock worth $334,000 after buying an additional 130 shares during the last quarter. Beck Capital Management LLC raised its stake in shares of VanEck Pharmaceutical ETF by 5.2% in the third quarter. Beck Capital Management LLC now owns 22,383 shares of the company’s stock valued at $2,127,000 after buying an additional 1,109 shares during the period. Finally, Miller Investment Management LP lifted its position in shares of VanEck Pharmaceutical ETF by 13.4% during the 3rd quarter. Miller Investment Management LP now owns 207,535 shares of the company’s stock valued at $19,722,000 after buying an additional 24,446 shares during the last quarter.

VanEck Pharmaceutical ETF Stock Performance

Shares of PPH opened at $92.64 on Friday. VanEck Pharmaceutical ETF has a fifty-two week low of $84.48 and a fifty-two week high of $99.51. The business has a 50-day moving average of $90.22 and a 200 day moving average of $91.03. The firm has a market cap of $578.07 million, a P/E ratio of 27.82 and a beta of 0.72.

VanEck Pharmaceutical ETF Increases Dividend

The firm also recently announced a dividend, which was paid on Monday, December 30th. Stockholders of record on Friday, December 27th were paid a $0.411 dividend. This is an increase from VanEck Pharmaceutical ETF’s previous dividend of $0.36. The ex-dividend date was Friday, December 27th.

About VanEck Pharmaceutical ETF

The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.